全文获取类型
收费全文 | 11586篇 |
免费 | 613篇 |
国内免费 | 108篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 206篇 |
妇产科学 | 130篇 |
基础医学 | 1355篇 |
口腔科学 | 153篇 |
临床医学 | 777篇 |
内科学 | 3342篇 |
皮肤病学 | 201篇 |
神经病学 | 756篇 |
特种医学 | 355篇 |
外科学 | 2247篇 |
综合类 | 67篇 |
预防医学 | 316篇 |
眼科学 | 138篇 |
药学 | 743篇 |
中国医学 | 35篇 |
肿瘤学 | 1373篇 |
出版年
2024年 | 8篇 |
2023年 | 114篇 |
2022年 | 217篇 |
2021年 | 367篇 |
2020年 | 208篇 |
2019年 | 281篇 |
2018年 | 367篇 |
2017年 | 229篇 |
2016年 | 354篇 |
2015年 | 355篇 |
2014年 | 439篇 |
2013年 | 504篇 |
2012年 | 889篇 |
2011年 | 928篇 |
2010年 | 490篇 |
2009年 | 394篇 |
2008年 | 716篇 |
2007年 | 784篇 |
2006年 | 730篇 |
2005年 | 733篇 |
2004年 | 675篇 |
2003年 | 549篇 |
2002年 | 601篇 |
2001年 | 112篇 |
2000年 | 97篇 |
1999年 | 109篇 |
1998年 | 111篇 |
1997年 | 106篇 |
1996年 | 80篇 |
1995年 | 73篇 |
1994年 | 78篇 |
1993年 | 62篇 |
1992年 | 51篇 |
1991年 | 44篇 |
1990年 | 32篇 |
1989年 | 33篇 |
1988年 | 50篇 |
1987年 | 37篇 |
1986年 | 32篇 |
1985年 | 34篇 |
1984年 | 42篇 |
1983年 | 27篇 |
1982年 | 14篇 |
1981年 | 27篇 |
1980年 | 27篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 17篇 |
1974年 | 10篇 |
1973年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
Asako Kitahara Akinori Ebihara Shohei Obayashi Yukihiro Horio Yoshitaka Ono Tomohiro Yoshikawa Naoki Okada Jun Tanaka Hiroto Takiguchi Naoki Hayama Yoko Ito Tsuyoshi Oguma Ichiro Kuwahira Koichiro Asano 《Internal medicine (Tokyo, Japan)》2022,61(8):1219
A 44-year-old man developed coronavirus disease 2019 (COVID-19) pneumonia during immunochemotherapy consisting of carboplatin, paclitaxel, and pembrolizumab for non-small cell lung cancer. Low-grade fever, followed by mild hypoxemia, and febrile neutropenia, were observed, and granulocyte colony-stimulating factor (G-CSF) was administered until the recovery of neutropenia, when he developed a high fever, severe hypoxemia, and hypotension accompanied by consolidation in the bilateral lungs. His conditions promptly improved after treatment including hydrocortisone and the primary and metastatic tumors remained regressed for 10 months without further treatment. Post-COVID-19 organizing pneumonia during cancer immunochemotherapy can be aggravated by immune-checkpoint inhibitors and G-CSF. 相似文献
93.
94.
Takahashi H Takeishi Y Seidler T Arimoto T Akiyama H Hozumi Y Koyama Y Shishido T Tsunoda Y Niizeki T Nozaki N Abe J Hasenfuss G Goto K Kubota I 《Circulation》2005,111(12):1510-1516
95.
96.
97.
Tomoyuki Asano Yuzuka Saito Naoki Matsuoka Jumpei Temmoku Yuya Fujita Kasumi Hattori Shunsuke Kobayashi Akira Ojima Toshiyuki Takahashi Haruki Matsumoto Makiko Yashiro-Furuya Shuzo Sato Hiroko Kobayashi Hiroshi Watanabe Kiori Yano Tomomi Sasajima Kazuo Fujihara Kiyoshi Migita 《Medicine》2021,100(15)
Rationale:Anti-myelin oligodendrocyte protein antibody-associated disease (MOGAD) is a new disease entity with various clinical phenotypes. MOGAD often present with recurrent optic neuritis (ON), and it can also develop as a compartment of neuromyelitis optica spectrum disorder (NMOSD). Moreover, multiple autoantibodies such as an anti-myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) had been reported in the serum of patients with NMOSD.Patient concerns:We report an 86-year-old woman with a 2-year history of microscopic polyangiitis (MPA). The patient had a rapid loss of vision in her left eye. No abnormal findings were observed on her left fundus, and she tested negative for MPO-ANCA upon admission. However, anti-MOG antibodies were observed in the patient''s serum and cerebrospinal fluid.Diagnosis:A diagnosis of MOGAD complicated with MPA was made.Interventions:The patient received twice steroid pulse therapy and oral azathioprine as maintenance therapy.Outcomes:Her vision rapidly recovered, and no subsequent relapse was observed during the 8-month observation period.Conclusion:To the best of our knowledge, this is the first case of MOGAD complicated with MPA, and steroid pulse therapy and azathioprine therapy were effective for ON caused by MOGAD. 相似文献
98.
Yushiro Endo Shin-ya Kawashiri Shimpei Morimoto Ayako Nishino Momoko Okamoto Sosuke Tsuji Ayuko Takatani Toshimasa Shimizu Remi Sumiyoshi Takashi Igawa Tomohiro Koga Naoki Iwamoto Kunihiro Ichinose Mami Tamai Hideki Nakamura Tomoki Origuchi Yukitaka Ueki Tamami Yoshitama Nobutaka Eiraku Naoki Matsuoka Akitomo Okada Keita Fujikawa Hideo Otsubo Hirokazu Takaoka Hiroaki Hamada Tomomi Tsuru Shuji Nagano Arinobu Yojiro Toshihiko Hidaka Yoshifumi Tada Atsushi Kawakami 《Medicine》2021,100(1)
We aimed to evaluate the utility of a simplified ultrasonography (US) scoring system, which is desired in daily clinical practice, among patients with rheumatoid arthritis (RA) receiving biological/targeted synthetic disease-modifying antirheumatic drugs (DMARDs).A total of 289 Japanese patients with RA who were started on tumor necrosis factor inhibitors, abatacept, tocilizumab, or Janus kinase inhibitors between June 2013 and April 2019 at one of the 15 participating rheumatology centers were reviewed. We performed US assessment of articular synovia over 22 joints among bilateral wrist and finger joints, and the 22-joint (22j)-GS and 22-joint (22j)-PD scores were evaluated as an indicator of US activity using the sum of the GS and PD scores, respectively.The top 6 most affected joints included the bilateral wrist and second/third metacarpophalangeal joints. Therefore, 6-joint (6j)-GS and -PD scores were defined as the sum of the GS and PD scores from the 6 synovial sites over the aforementioned 6 joints, respectively. Although the 22j- or 6j-US scores were significantly correlated with DAS28-ESR or -CRP scores, the correlations were weak. Conversely, 6j-US scores were significantly and strongly correlated with 22j-US scores not only at baseline but also after therapy initiation.Using a multicenter cohort data, our results indicated that a simplified US scoring system could be adequately tolerated during any disease course among patients with RA receiving biological/targeted synthetic DMARDs. 相似文献
99.
100.
Masami Kosuge Kazuo Kimura Toshiyuki Ishikawa Tomoaki Shimizu Takeshi Takamura Kengo Tsukahara Yoshio Tahara Naoki Nozawa Eri Furukawa Osamu Tochikubo Mitsugi Sugiyama Satoshi Umemura 《Circulation journal》2004,68(6):526-531
BACKGROUND: The clinical significance of the white blood cell (WBC) count on admission in relation to the duration of ischemia in acute myocardial infarction (AMI) remains unclear. METHODS AND RESULTS: The relationship of the WBC count on admission to myocardial reperfusion was examined in 135 patients with recanalization of an anterior AMI within 6 h of symptom onset. Patients were classified according to the WBC count on admission: Group L (n=75), WBC count <12,000 cells/mm(3) and group H (n=60), WBC count >or=12,000 cells/mm(3). Peak creatine kinase (CK) was higher and impaired myocardial reperfusion, defined as a myocardial blush grade of 0/1, was more frequent in group H than in group L. Among the patients in group H, those with early (3 h) recanalization; however, peak CK and the incidence of impaired myocardial reperfusion were similar in these subgroups of patients. Multivariate analysis showed that WBC count >or=12,000 cells/mm(3) on admission was an independent predictor of impaired myocardial reperfusion in patients with early recanalization (odds ratio 7.9, p=0.04), but not in those with late recanalization. CONCLUSIONS: A higher WBC count may be associated with progression of myocardial damage after recanalization in patients with early recanalization of an anterior AMI. 相似文献